Loading clinical trials...
Loading clinical trials...
Tracing the Metabolic Flux of Orally Administered NAD+ Precursors in Healthy Young and Older Adults
Conditions
Interventions
Nicotinamide Mononucleotide (NMN)
Nicotinamide (NAM)
Locations
1
United States
Brigham and Women's Hospital
Boston, Massachusetts, United States
Start Date
April 28, 2025
Primary Completion Date
December 1, 2026
Completion Date
June 1, 2027
Last Updated
May 6, 2025
NCT07227259
NCT06815991
NCT07305753
NCT06011018
NCT07130825
NCT05188079
Lead Sponsor
Metro International Biotech, LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions